Showing results (321-330 of 554) with videos related to
Sort By:
Pageof 56
JAMA Oncology|July 17, 2015
Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate CancerEmmanuel S Antonarakis, Changxue Lu, Brandon Luber, et al.Molecular Cancer Research : MCR|June 24, 2024
Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate CancerSharon H Choi, Elizabeth Pan, Andrew Elliott, et al.Investigational New Drugs|November 20, 2015
A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) studyManish K Thakur, Lance K Heilbrun, Shijie Sheng, et al.Prostate Cancer and Prostatic Diseases|March 2, 2024
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancerNeal D Shore, Emmanuel S Antonarakis, Ashley E Ross, et al.Urologic Oncology|August 6, 2011
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancerJianqing Lin, Marianna Zahurak, Tomasz M Beer, et al.International Journal of Molecular Sciences|July 19, 2013
Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancerSara Alcorn, Amanda J Walker, Nishant Gandhi, et al.NPJ Precision Oncology|December 2, 2024
Intratumoral heterogeneity drives acquired therapy resistance in a patient with metastatic prostate cancerDena P Rhinehart, Jiaying Lai, David E Sanin, et al.Medicina (Kaunas, Lithuania)|December 23, 2022
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum AgentsSourat Darabi, David R Braxton, Joanne Xiu, et al.The Prostate|June 25, 2016
Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN StudyMichael T Schweizer, Hao Wang, Brandon Luber, et al.The Prostate|July 31, 2019
A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancerChanning J Paller, Danilo Piana, James R Eshleman, et al.Pageof 56